ATP9A-EPB41L1 Fusion FISH Probe
The ATP9A-EPB41L1 Fusion FISH Probe is used to confirm a fusion of the ATP9A and EPB41L1 genes. The fusion of the ATP9A and EPB41L1 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ATP9A-EPB41L1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ATP9A-EPB41L1-20-AQAQ | 20 (40 μL) | 200 μL |
|
EPB41L1 Gene Summary
Erythrocyte membrane protein band 4.1 (EPB41) is a multifunctional protein that mediates interactions between the erythrocyte cytoskeleton and the overlying plasma membrane. The encoded protein binds and stabilizes D2 and D3 dopamine receptors at the neuronal plasma membrane. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2015]
Gene Name: Erythrocyte Membrane Protein Band 4.1 Like 1
Chromosome: CHR20: 34700347 -34820721
Locus: 20q11.23
ATP9A Gene Summary
The ATPase Phospholipid Transporting 9A (putative) (ATP9A) gene is located on chr20 :50213313-50384908 at 20q13.2.
Gene Name: ATPase Phospholipid Transporting 9A (putative)
Chromosome: CHR20: 50213313 -50384908
Locus: 20q13.2
Gene Diseases
The ATP9A EPB41L1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|